Literature DB >> 20831712

CD23/FcεRII: molecular multi-tasking.

M Acharya1, G Borland, A L Edkins, L M Maclellan, J Matheson, B W Ozanne, W Cushley.   

Abstract

CD23 is the low-affinity receptor for immunoglobulin (Ig)E and plays important roles in the regulation of IgE responses. CD23 can be cleaved from cell surfaces to yield a range of soluble CD23 (sCD23) proteins that have pleiotropic cytokine-like activities. The regions of CD23 responsible for interaction with many of its known ligands, including IgE, CD21, major histocompatibility complex (MHC) class II and integrins, have been identified and help to explain the structure-function relationships within the CD23 protein. Translational studies of CD23 underline its credibility as a target for therapeutic intervention strategies and illustrate its involvement in mediating therapeutic effects of antibodies directed at other targets.
© 2010 The Authors. Clinical and Experimental Immunology © 2010 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20831712      PMCID: PMC2990925          DOI: 10.1111/j.1365-2249.2010.04210.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  127 in total

1.  Food allergens are protected from degradation during CD23-mediated transepithelial transport.

Authors:  Claudia Bevilacqua; Guillaume Montagnac; Alexandre Benmerah; Céline Candalh; Nicole Brousse; Nadine Cerf-Bensussan; Mary H Perdue; Martine Heyman
Journal:  Int Arch Allergy Immunol       Date:  2004-09-02       Impact factor: 2.749

2.  BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.

Authors:  D A Thorley-Lawson; L M Nadler; A K Bhan; R T Schooley
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

3.  Ligation of the CD23,p45 (BLAST-2,EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes.

Authors:  J Gordon; M Rowe; L Walker; G Guy
Journal:  Eur J Immunol       Date:  1986-09       Impact factor: 5.532

4.  Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia.

Authors:  M Sarfati; D Bron; L Lagneaux; C Fonteyn; H Frost; G Delespesse
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

5.  Molecular structure of the gene and the 5'-flanking region of the human lymphocyte immunoglobulin E receptor.

Authors:  U Suter; R Bastos; H Hofstetter
Journal:  Nucleic Acids Res       Date:  1987-09-25       Impact factor: 16.971

6.  Expression and functional role of CD23 on T cells.

Authors:  R J Armitage; L K Goff; P C Beverley
Journal:  Eur J Immunol       Date:  1989-01       Impact factor: 5.532

7.  Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression.

Authors:  A Yokota; H Kikutani; T Tanaka; R Sato; E L Barsumian; M Suemura; T Kishimoto
Journal:  Cell       Date:  1988-11-18       Impact factor: 41.582

8.  Cloning and expression of the cDNA coding for a human lymphocyte IgE receptor.

Authors:  C Lüdin; H Hofstetter; M Sarfati; C A Levy; U Suter; D Alaimo; E Kilchherr; H Frost; G Delespesse
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

9.  Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes.

Authors:  D Vercelli; H H Jabara; B W Lee; N Woodland; R S Geha; D Y Leung
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

10.  Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.

Authors:  T Defrance; J P Aubry; F Rousset; B Vanbervliet; J Y Bonnefoy; N Arai; Y Takebe; T Yokota; F Lee; K Arai
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  57 in total

1.  Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells.

Authors:  Aleta Pupovac; Nicholas J Geraghty; Debbie Watson; Ronald Sluyter
Journal:  Immunol Cell Biol       Date:  2014-08-26       Impact factor: 5.126

Review 2.  Innate and adaptive immune responses in asthma.

Authors:  Stephen T Holgate
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

Review 3.  Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases.

Authors:  Oliver T Burton; Hans C Oettgen
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

Review 4.  Regulation of IgE Responses by γδ T Cells.

Authors:  Yafei Huang; Zhifang Yang; Jessica McGowan; Hua Huang; Rebecca L O'Brien; Willi K Born
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

5.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

6.  Cell surface antigen profiling using a novel type of antibody array immobilised to plasma ion-implanted polycarbonate.

Authors:  Heather Main; Jelena Radenkovic; Elena Kosobrodova; David McKenzie; Marcela Bilek; Urban Lendahl
Journal:  Cell Mol Life Sci       Date:  2014-03-13       Impact factor: 9.261

Review 7.  Roles of extracellular nucleotides and P2 receptors in ectodomain shedding.

Authors:  Aleta Pupovac; Ronald Sluyter
Journal:  Cell Mol Life Sci       Date:  2016-05-14       Impact factor: 9.261

8.  Detection of immunoglobulin isotypes from dried blood spots.

Authors:  Nancy J Andersen; Tapan Kumar Mondal; Mark T Preissler; Brian M Freed; Sabine Stockinger; Erin Bell; Charlotte Druschel; Germaine M Buck Louis; David A Lawrence
Journal:  J Immunol Methods       Date:  2013-12-13       Impact factor: 2.303

Review 9.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

10.  Admixture of beneficial and unfavourable variants of GLCCI1 and FCER2 in Roma samples can implicate different clinical response to corticosteroids.

Authors:  Renata Szalai; Petra Matyas; Dalma Varszegi; Marton Melegh; Lili Magyari; Luca Jaromi; Katalin Sumegi; Balazs Duga; Erzsebet Kovesdi; Kinga Hadzsiev; Bela Melegh
Journal:  Mol Biol Rep       Date:  2014-08-05       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.